The Korean Ministry of Food and Drug Safety approved Catalyst Biosciences Inc.'s (Nasdaq: CBIO) Investigational New Drug Application for CB 2679d/ISU304. The stock price more than doubled by leaping $9.86 to close at $15.01.
Catalyst Biosciences' NDA approved
March 28, 2017 at 16:39 PM EDT
